Prevalence and Age at Diagnosis of Risk Factors for Severe Respiratory Syncytial Virus Disease Among US Adults: An Analysis of 2011–2020 NHANES Data

Documenti analoghi

• Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus
  di: Ann R. Falsey, et al.
  Pubblicazione: (2024)
• Burden of Respiratory Syncytial Virus (RSV) Infection Among Adults in Nursing and Care Homes: A Systematic Review
  di: Richard Osei‐Yeboah, et al.
  Pubblicazione: (2024)
• Unveiling the Spectrum of Respiratory Syncytial Virus Disease in Adults: From Community to Hospital
  di: Koos Korsten, et al.
  Pubblicazione: (2025)
• Correction to: The Respiratory Syncytial Virus Prefusion F Protein Vaccine Attenuates the Severity of RSV‐Associated Disease in Breakthrough Infections in Adults ≥60 Years of Age
  Pubblicazione: (2024)
• Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019
  di: Caihua Liang, et al.
  Pubblicazione: (2025)